ZLDPF OTC
Zealand Pharma A/S
1W: -4.7%
1M: -15.4%
3M: -12.3%
YTD: -44.6%
1Y: -47.9%
3Y: -4.8%
5Y: +43.6%
$40.00
+1.90 (+4.99%)
Weekly Expected Move ±8.2%
$33
$37
$40
$43
$47
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$16.4B
+72.8% ▲
5Y CAGR: +53.5%
Total Liabilities
$1.6B
+83.1% ▲
5Y CAGR: +16.8%
Shareholders Equity
$14.8B
+71.7% ▲
5Y CAGR: +65.9%
Cash & Investments
$15.1B
+83.3% ▲
5Y CAGR: +67.1%
Total Debt
$485M
+23.8% ▲
5Y CAGR: +32.3%
Net Debt
-$4.1B
-4509.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.1B | $1.1B | $449M | $480M | $4.6B |
| Short-Term Investments | $299M | $109M | $1.2B | $7.7B | $10.5B |
| Cash & ST Investments | $1.4B | $1.2B | $1.6B | $8.2B | $15.1B |
| Net Receivables | $153M | $116M | $122M | $139M | $319M |
| Inventory | $118M | $1M | $8M | $11M | $0 |
| Other Current Assets | -$43M | $22M | $16M | $46M | $6 |
| Total Current Assets | $1.7B | $1.3B | $1.8B | $8.5B | $15.6B |
| Property, Plant & Equip. | $221M | $165M | $150M | $125M | $151M |
| Goodwill & Intangibles | $54M | $71M | $12M | $13M | $45M |
| Long-Term Investments | $27M | -$71M | $21M | -$6.9B | $20M |
| Other Non-Current Assets | $30M | $56M | $37M | $7.8B | $61M |
| Total Non-Current Assets | $346M | $223M | $200M | $978M | $790M |
| Total Assets | $2.1B | $1.5B | $2.0B | $9.5B | $16.4B |
| — Liabilities — | |||||
| Accounts Payable | $266M | $181M | $92M | $181M | $256M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $23M |
| Deferred Revenue | $53M | -$15M | $0 | $0 | $65M |
| Other Current Liabilities | $0 | $0 | $176M | $167M | $206M |
| Total Current Liabilities | $334M | $195M | $285M | $403M | $663M |
| Long-Term Debt | $648M | $321M | $0 | $285M | $382M |
| Other Non-Current Liab. | $33M | $100M | $0 | $110M | -$10M |
| Total Non-Current Liabilities | $806M | $528M | $103M | $485M | $964M |
| Total Liabilities | $1.1B | $724M | $387M | $889M | $1.6B |
| — Equity — | |||||
| Common Stock | $44M | $52M | $59M | $71M | $71M |
| Retained Earnings | -$3.3B | -$4.2B | -$4.9B | -$6.2B | $6M |
| Accumulated OCI | $14M | $764M | $23M | $22M | $23M |
| Total Stockholders Equity | $928M | $816M | $1.6B | $8.6B | $14.8B |
| Total Liabilities & Equity | $2.1B | $1.5B | $2.0B | $9.5B | $16.4B |
| — Key Metrics — | |||||
| Total Debt | $787M | $443M | $119M | $392M | $485M |
| Net Debt | -$342M | -$626M | -$330M | -$89M | -$4.1B |
| Total Investments | $326M | $38M | $21M | $820M | $10.5B |